Live Breaking News & Updates on Duality Biologics Suzhou Co
Stay updated with breaking news from Duality biologics suzhou co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase 3 clinical trial evaluating BNT323/DB-1303 in HR+ HER2-low. ....
Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase 3 clinical trial evaluating. ....